Abstract
The doctrine of informed consent is fundamental to all medical personnel involved in investigational research. Informed consent arose from the Helsinki declaration that stated, "concern for the interests of the subject must always prevail over the interests of science and society." (6) As clinical research is a part of medical practice, it is reasonable to assume that exceptions to fully informed consent that are defendable in medical practice can be applied to clinical research as well. The exceptions to fully informed consent are waiver, incompetence, therapeutic priviledge, emergency, or proxy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 99-112 |
| Number of pages | 14 |
| Journal | Clinical Research and Regulatory Affairs |
| Volume | 8 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 1 1990 |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmaceutical Science
- Pharmacology (medical)
Fingerprint Dive into the research topics of 'Exceptions to fully informed consent in clinical Research'. Together they form a unique fingerprint.
Cite this
Larsen, K. E., & Hilleman, D. E. (1990). Exceptions to fully informed consent in clinical Research. Clinical Research and Regulatory Affairs, 8(2), 99-112. https://doi.org/10.3109/10601339009024025